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Abstract 
 
Background: High and growing prevalence rates of hypertension in South Africa. 
Consequently, there is a need to assess knowledge and management among hypertensive 
patients receiving chronic medication from primary health care (PHC) facilities in South Africa 
as a basis for improving future management. This is important as South Africa seeks to improve 
its management of chronic diseases. Method: Descriptive, quantitative study amongst chronic 
hypertensive patients in the chronic disease programme. Patients were interviewed face-to-face 
by trained pharmacists using a structured questionnaire. Data analysis included descriptive and 
inferential statistics. Results: Half (53.7%) of the patients had uncontrolled BP. Less than a 
third of patients (27.7%) knew what hypertension is, the meaning of recorded BP numbers 
(4.5%), and what normal BP should be (19.9%). All patients who knew the meaning of BP 
numbers had formal education (p=0.047). Only 15.6% of the 56.0% patients, who received 
hypertension information, received it on antihypertensive medicines specifically. Conclusions: 
Majority of the patients lacked hypertension specific knowledge and only half had controlled 
BP. Interventions to improve the control of high BP should be targeted at closing knowledge 
gaps as part of the current chronic treatment initiatives to ensure the benefits of increased access 
to care are realized. 
 
Keywords: Chronic medication, hypertension, knowledge, primary health care, South Africa 
 
1. Introduction 
 
Globally, non-communicable diseases (NCDs) account for 63% of disease burden [1], with 
deaths caused by NCDs rising up to 70% by 2020  [1, 2], and high blood pressure (BP) 
associated with up  to 9.4 million deaths annually and rising [3-5]. Presently, three out of four 
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patients with hypertension live in low and middle income countries (LMICs), accounting for 
nearly 80% of total deaths, with the highest prevalence in Africa [4-7]. 
 
The burden of NCDs in South Africa (SA) has increased in the past decade, with mortality due 
to NCDs similar across SA [2]. Currently, the public health care system in SA is faced with 
major challenges due to Human Immunodeficiency Virus (HIV) and Acquired Immune 
Deficiency Syndrome (AIDS), tuberculosis (TB), injury and violence, maternal and child 
health related issues as well as NCDs like hypertension and diabetes [8], with up to 70% of 
women and a third of men overweight or obese [9]. Published estimates suggest up to 78% of 
those aged 50 or older have hypertension [10], with hypertensive diseases now the seventh 
underlying cause of death and a major contributor to cardiovascular disease in SA [11]. 
Hypertension also accounts for the greatest reason why patients with NCDs visit primary health 
care (PHC) facilities in SA [12].    
 
Inadequate management of hypertension is the result of a number of factors including a lack of 
resources and lifestyle modifications, non-adherence to medication, and a lack of 
understanding of the disease [7,13-19], with non-adherence rising  in low and middle income 
countries (LMIC) due to lack of resources and access [7]. Patients who have hypertension 
knowledge can participate in the management of their disease [7,20-22], with the inability to 
read and interpret medication instructions and BP readings contributing to uncontrolled BP 
[23-25]. Evidence has also shown that little or no education increases the possibility of having 
hypertension or its complications [22,24-26].  
 
To ensure universal health coverage for all South Africans, the government introduced the 
National Health Insurance (NHI) in 2012 to unfold over the next 14 years [27,28], designed to 
provide access to affordable quality health services for all based on their health needs, 
irrespective of their socio-economic status [27]. To improve the availability and accessibility 
of medicines to patients with chronic diseases, the government has recently introduced the 
Central Chronic Medicines Dispensing and Distribution (CCMDD) programme [27,28]. 
Patients who are stable on treatment would visit health care facilities at 6-monthly intervals for 
a clinical assessment. Monthly prescriptions are collected from the health care facility, or from 
a registered pick-up point, to enhance access, aiming to improve retention and adherence [28]. 
 
However, even though medicines are free to treat hypertension, it was found that the majority 
of hypertensive patients on chronic treatment at PHC facilities are not well controlled [19]. The 
lack of hypertension specific knowledge and the lack of literacy among hypertensive patients, 
similar to other studies, were suggested as possible reasons for uncontrolled hypertension in 
SA [19,21-26].  
 
2. Aims 
 
This study aimed to build on previous studies to determine current knowledge among 
hypertensive patients collecting their chronic medication from PHC facilities in South Africa.  
This is important for the successful implementation of NHI and CCMDD programmes. 
 
3. Method 
 
3.1 Study setting  
The study was conducted at 50 PHC facilities, which included 42 PHC clinics and eight 
community health care (CHC) centres in the Vhembe District of Limpopo Province, which is 
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one of the NHI pilot districts in SA for the CCMDD programme. Health care services in the 
district are delivered by district hospitals, PHC facilities and mobile services in four sub-
districts. Primary care is typically the first point of contact that patients have with the public 
health care service in SA, with 84% of the population treated in the public system [12]. 
 
3.2 Study design 
A descriptive, quantitative operational study was conducted among chronic hypertensive 
patients collecting their medication from PHC facilities in the Vhembe District.  
 
3.3 Study population and sample 
Convenient and consecutive sampling was used to recruit between one and 15 hypertensive 
patients at each of the 50 PHC facilities as part of normal facility operations. This resulted in a 
final sample of 253 patients. Patients were recruited either before or after the collection of their 
medicines, after consultation with the nurse or medical practitioner, as long as their vital signs 
such as blood pressure (BP) and weight had been taken by one of the health care staff.  The 
inclusion criteria were adult patients \HDUVSDWLHQWVRQFKURQLFDQWLK\SHUWHQVLYHWUHDWPHQW
the ability to speak and understand English, Tshivenda or Tsonga, and willingness to participate 
in the study. Patients with complications based on their noted clinical characteristics such as 
pregnancy-related hypertension, patients with secondary hypertension, kidney or liver failure 
were excluded from this study. Exclusion criteria were identified by the examining nurse or 
medical practitioner. No attempt was made to document the number of patients not meeting 
the inclusion criteria since the focus was on recruiting patients for the study.  
 
3.4 Data collection procedures and data collection instrument 
Data were collected over a three-month period, between June and August 2015. A structured 
questionnaire was administered in a face-to-face interview by trained pharmacists visiting the 
PHC facilities as part of routine practice WRDVVHVVSDWLHQWV¶NQRZOHGJHRQK\SHUWHQVLRQDQGLWV
management. The questionnaire was developed and adapted based on questionnaires used in 
other studies [29-31], after which it was pretested among 20 hypertensive patients on treatment 
prior to the commencement of the study, to ascertain the suitability and feasibility of the 
questionnaire for the specific study population. Subsequently, a few amendments were made 
to the questionnaire, bDVHG RQ WKH UHVSRQGHQWV¶ LQWHUSUHWDWLRQ DQG XQGHUVWDQGLQJ RI WKH
questions. As a result, enhance the robustness and validity of the questionnaire. 
 
PDWLHQWV¶UHVSRQVHVwere recorded on the questionnaire. Physical measurements of BP, taken 
on the day of the interview as part of normal practices were recorded from the patientV¶ files. 
Resting BP was typically measured by nurses trained on the procedure, with measurement on 
either arm either using a digital automatic BP monitor, in one third of clinics, or a 
sphygmomanometer, in two thirds of clinics, depending on availability. A mobile stadiometer 
and a column standing scale, with patients wearing light clothing and no shoes, were used to 
measure height and weight respectively. Patients were asked about their social habits, which 
included how many times in a week or month they drink alcohol without requesting the unit of 
alcohol or number of alcoholic drinks, and whether they smoked. If so, how many cigarettes 
they smoke per day. 
 
3.5 Data analysis 
'DWD ZHUH FDSWXUHG RQ 0LFURVRIW ([FHO VSUHDG VKHHWV, checked for correctness and 
discrepancies rectified prior to data analysis. Statistical analyses were performed on SAS 
version 9.4. Data were summarised by frequency counts and percentages for the categorical 
variables and subgroups. Means with standard deviation (SD) and medians with quartiles (Q) 
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were calculated for continuous variables. Hypertensive patients with formal education and 
those without were compared in terms of hypertension knowledge. Statistical tests were two-
sided and p-YDOXHVZHUHFRQVLGHUHGsignificant. Responses to open-ended questions were 
manually categorised to enable the counting of responses within the different categories, and 
summarised as frequency counts and percentages.  
 
3.6 Ethical considerations   
Ethical clearance for the study was obtained from the Medunsa Research Ethics Committee of 
the University of Limpopo (currently Sefako Makgatho Health Sciences University) before 
commencement of the study (MREC/H/ 27/2014: PG). Permission to conduct the study was 
obtained from the Limpopo Department of Health and Vhembe District Executive Manager. 
All patients provided written informed consent to participate in the study. Each patient was 
allocated a unique study number and no personal details were recorded. 
 
4. Results  
 
4.1 Socio-demographic and clinical characteristics 
The socio-demographic and clinical characteristics of the patients, distributed by gender, are 
presented in Table 1. All study patients (n=253) were black Africans, with a mean age of 62.7 
(SD: 13.6) years and females predominating (81.9%). The vast majority (86.6%) of the 112 
patients (where weight was recorded had a body mass index (BMI) above normal (>25) with a 
mean and median BMI of 31.8 (SD 7.4) and 30.5 (Q1:26.6; Q3:34.6) respectively (Table 1). 
 
Table 1: Socio-demographic and clinical characteristics of patients by gender 
 
Patient characteristics 
Female Male Total 
No (%)* No (%)* No (%)* 
Age group (years) Up to 30 2 (0.8) 0 2 (0.8) 
31-40 7 (3.0) 0 7 (3.0) 
41-50 27 (11.4) 4 (1.7) 31 (13.1) 
51-60 53 (22.4) 9 (3.8) 62 (26.2) 
61-70 63 (26.6) 16 (6.8) 79 (33.3) 
>70 42 (17.7) 14 (6.0) 56 (23.6) 
Total  194 (81.9) 43 (18.1) 237 (100.0) 
Education  None  113 (46.9) 22 (9.1) 135 (56.0) 
Primary education 55 (22.8) 13 (5.4) 68 (28.2) 
Secondary education 25 (10.4) 5 (2.1) 30 (12.5) 
Tertiary education 6 (2.5) 2 (0.8) 8 (3.3) 
Total  199 (82.6) 42 (17.4) 241 (100.0) 
Body mass index 
(BMI) 
1RUPDO%0, 11 (9.8) 4 (3.6) 15 (13.4) 
Above normal (BMI > 25) 84 (75.0) 13 (11.6) 97 (86.6) 
Total  95 (84.8) 17 (15.2) 112 (100) 
Hypertension 
levels35 
Mild (SBP: 140-159 mmHg; DBP: 90-99 mmHg) 76 (31.7) 
Moderate (SBP: 160-179 mmHg; DBP: 100-109 mmHg) 34 (14.2) 
Severe 6%3PP+J'%3PP+J 19 (7.9) 
Controlled (SBP: <140 mmHg; DBP: <90 mmHg) 111 (46.3) 
Total  240 (100) 
Blood pressure 
(BP) 
Median (Q1;Q3) systolic BP 140 (120;155) 
Mean (SD) systolic BP 139.0 (22.5) 
Median (Q1;Q3) diastolic BP 80.0 (74;90) 
Mean (SD) diastolic BP 81.1 (12.5)  
History of 
hypertension 
Known family history 121 (48.6) 
No family history 92 (51.4) 
Did not know whether family history or not 36 (14.5) 
Total 249 (100) 
Co-morbidity  Co-morbidity  121 (51.3) 
No co-morbidity 115 (48.7) 
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Totals  236 (100) 
*Percentage of total sample; Data for some patients were not available, hence difference in sample size 
BP: Blood pressure; BMI: Body mass index SD: Standard deviation; Q: Quartile. SBP: systolic blood pressure, DBP diastolic blood 
pressure 
 
4.2 Hypertension, family history and co-morbidities 
More than half (59.5%) of the patients had been on treatment for hypertension for more than 
five years, with only 46.3% of the patients presenting on the day of the interview with 
controlled hypertension (Table 1).   
 
Nearly half (48.6%) of the patients indicated they have a family history of hypertension, while 
14.5% did not know whether they have a family member with hypertension or not. Half of the 
patients who reported a family history of hypertension (49.6%), had a mother with 
hypertension. Co-morbidities were present in approximately half of the patients, of whom 
approximately half had diabetes as a co-morbidity (Table1).  
 
4.3 Knowledge of hypertension as a chronic condition 
7DEOHSUHVHQWVDVXPPDU\RISDWLHQWV¶knowledge of various aspects of hypertension by level 
of education. Less than a quarter (18.75%) of the patients knew what normal BP should be, 
with significantly more who knew having some form of education (83.3%; p<0.001) compared 
to those without formal education (16.7%). Similarly, significantly more patients with formal 
education (68.4%; p=0.013) knew the definition of high BP. At least 50% of patients knew 
what causes hypertension and of those, 58.3% had formal education (p<0.001). Some of the 
patients (13.4%) did not know that high BP is dangerous to their health and 9.4% did not know 
the dangers of uncontrolled high BP. 
 
The following verbatim quotations illustrate SDWLHQWV¶ lack of knowledge or misperception 
about the causes of hypertension: 
 
³,GRQ¶WNQRZEHFDXVHIRUPHLWFDPHwhen I was sleeping.´  
[62 year old female; no education; SBP: 138 mmHg and DBP: 83 mmHg] 
 
³$V\RXJURZROGHUDQGVWRSPHQVWUXDWLQJ.´  
[Female; SBP: 160 mmHg and DBP: 80 mmHg; no education] 
 
³:RUNLQJLQGXVW\SODFHV.´  
[64 years old male; SBP: 124 mmHg and DBP: 64 mmHg; completed primary education] 
 
The following statement shows that patients had some counselling on the causes of 
hypertension, though does not necessarily imply that the patient had hypertension as a result 
of taking contraceptives. 
  
³&RQWUDFHSWLYHV´  
[67 year old female; SBP: 160 mmHg and DBP: 60 mmHg; no education] 
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Table 2: Hypertension specific knowledge per educational level 
 
 
4.4 Knowledge of blood pressure measurement  
A third (38.4%) of the patients knew how BP readings are recorded, and of those, 73.1% 
(p<0.001) had some form of education. Only 10 patients (4.2%) knew that both systolic and 
diastolic blood pressure recordings are important to indicate whether BP is controlled or not, 
and only five patients (2.1%) knew the meaning of the numbers reported for BP, of whom all 
had some form of formal education (p=0.047) (Table 2).  
 
4.5 Knowledge of the treatment of hypertension with medicines 
The majority of patients (98.8%) knew that taking anti-hypertensive medicines as prescribed 
is important to control BP and 83.7% knew the benefits of taking these medicines correctly. 
 
4.6 Lifestyle practices 
A minority of patients (4.3%) did not know that smoking is dangerous to health and 4.7% did 
not know that excessive alcohol is dangerous to hypertensive patients (Table 2). 
 
Table 3 SUHVHQWVSDWLHQWV¶VRFLDOlifestyle habits as reported during the interview, i.e. physical 
activity, use of alcohol and smoking. More than half (59.8%) of the patients indicated that they 
were doing some form of physical activity, of which the most common activity was playing 
soccer. Another common activity was jogging; however, the frequency of jogging was not well 
explained. Very few (3.6%) patients indicated that they consumed alcohol, and only 11.6% 
indicated that they were smoking, either cigarettes or snuff. Of the 29 patients who confirmed 
that they were smoking, nine indicated they smoked one to five cigarettes per day. 
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7DEOH3DWLHQWV¶OLIHVW\OHSUDFWLFHV 
 
Lifestyle practices n 
Patients 
No (%) 
Participate in physical activity 249 149 (59.8) 
Use alcohol 250 9 (3.6) 
Frequency of alcohol use* 2-3 per week 9 1 (11.1) 
 2-4 per week 9 4 (44.4) 
 4+ per week 9 1 (11.1) 
 Monthly or less 9 3 (33.4) 
Smoke cigarettes or snuff 251 29 (11.6) 
Frequency of smoking 
1-5 per day 29 9 (31.0) 
6-10 per day 29 3 (10.3) 
Varies 29 2 (6.9) 
No data 29 14 (48.3) 
*Number of times per week or month alcohol is consumed, without specifying the units of alcohol or the number of drinks. 
 
4.7 Knowledge of lifestyle modification 
Less than half of the patients indicated that they were aware of the fact that they can do 
something such as exercise to help  control their BP (Table 2). Table 4 presents the lifestyle 
modification as reported by these patients. Half  of these indicated that to reduce, or stop, salt 
intake can reduce high BP. Nearly a third indicated that reducing stress can assist with reducing 
high BP. A few (13.2%) mentioned other activities such as limiting sugar intake, going to 
church or praying, stopping smoking and alcohol, eating grape fruit and talking to doctors 
(Table 4). 
 
Table 4: Knowledge of lifestyle modification which can reduce high BP  
 
Lifestyle modification 
Patients* 
n No. (%) 
Reduce or stop salt intake 114 58 (50.9) 
Avoid stress or always be happy 114 35 (30.7) 
Taking medicines correctly and on time 114 28 (24.6) 
Exercise or jogging 114 24 (21.1) 
Drink a lot of water 114 22 (19.3) 
Avoid fatty food 114 17 (14.9) 
Eat bitter vegetables 114 11 (9.6) 
Others 114 15 (13.2) 
*More than one response per patient possible 
 
4.8 Hypertension information 
The sample size (n) refers to the number of patients from whom data were available. More than 
half (56.0%; 136, n=244) of the patients indicated that they received information regarding 
hypertension at the PHC facilities during their consultation or when collecting their anti-
hypertensive medication. However only 47.1% (64, n=136) could specify what kind of 
information they received (see Figure 1). Information most commonly referred to address 
lifestyle practices. This included information on diet (37.5%, 24, n=64), lifestyle (31.3%, 20, 
n=64), and BMI (1.6%, 1, n=64). Only 15.6% (10, n=64) of the patients indicated that they 
received specific information on anti-hypertension medicines. Dangers and complications, 
signs and symptoms, and hypertension in general was mentioned by less than 10% of patients 
and 7.8% (5, n=54) of patients indicated that they could not remember what information they 
received (Figure1). 
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Figure 1: Hypertension information received (n=64) 
 
 
 
Note: Some patients mentioned more than one item 
 
The vast majority (95%, 232, n=244)  of patients indicated that they needed more information 
about hypertension, of whom only half (51.7%, 120, n=232) indicated what information they 
needed. Most (70.8%, 85, n=120) indicated the need for information about hypertension in 
general. Almost a quarter, who could specify the information they received, indicated the need 
to receive more information on lifestyle changes (23.3%, 28, n=120), with only 5.0% (6, 
n=120) indicating the need for information on hypertension medication and 2.5% (3, n=120) 
not being sure of what information they need (Figure 2).  
 
Figure 2:  Hypertension information patients would like to receive (n=120) 
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5. Discussion  
 
This study explored the knowledge of hypertension and its management among 253 chronic 
hypertensive patients in SA. The majority (81.9%) of patients were female, and more than half 
were older than 60 years with a mean age of 62.7 (SD:13.63) years (Table 1). This is consistent 
with studies previously conducted in South Africa and Botswana [11,19,32-34]. This is 
important as the prevalence of hypertension in this group may be related to aging [3,32]. Less 
than half of the patients (46.3%) in this study had controlled hypertension (SBP <140mmHg 
and DBP <90mmHg) as per the South African Standard Treatment Guidelines [35] (Table 1), 
consistent with previous studies in SA and in Pakistan [22,33]. 
 
Half of the patients had a family history of hypertension (Table 1), and in the vast majority of 
these patients, this was on the mother¶s side. This suggests the possibility that hypertension in 
these patients is genetic on the maternal side, consistent with previous studies in SA and 
Botswana [19, 33, 34].  Higher prevalence rates among women could also be related to a higher 
prevalence of obesity among women in SA compared to men [9,36]. 
 
More than half of the patients did not have any formal education (Table 1), and less than a 
quarter of those who had some form of education had a tertiary qualification. This high rate of 
illiteracy is a concern if only typed instructions are given to patients. Without formal education, 
coupled with lack of health care literacy about hypertension including how to manage it and 
appropriate lifestyle changes, as well as not remembering what information has been received 
(Tables 2 and 4, Figure 1), similar to other studies [3,32,37], this can impact negatively on BP 
control [21-26], increasing the rate of uncontrolled hypertension. This contributes to the high 
rates of uncontrolled hypertension seen in our study (Table 1). Consequently, health care 
practitioners need WR FRQWLQXRXVO\ DVVHVV K\SHUWHQVLYH SDWLHQWV¶ NQRZOHGJH to address key 
knowledge gaps with appropriate information including oral information. The latter is 
important given the high illiteracy rate in these patients.  
 
Encouragingly, the majority of patients knew that hypertension is dangerous to their health and 
that taking antihypertensive medication as prescribed, or advised by the pharmacist, is 
necessary to control their BP (Table 2). This is similar to a study conducted in Nigeria [29]. 
This  suggests that patients are likely to comply with their medicines with increasing 
knowledge about the benefits of taking their medicines, similar to other studies [21-25]. 
2YHUDOOLQFUHDVLQJSDWLHQWV¶NQRZOHGJHFDQLPSURYHK\SHUWHQVLRQPDQDJHPHQW>-22].  
 
Of concern is that less than half of the patients could explain what high BP is despite an 
appreciable number of patients on treatment for five years or longer (Table 2). Very few 
patients were aware as to how BP readings are recorded in their files and understood the 
meaning of the numbers. In addition, only a few patients knew what normal BP should be, an 
indication that patients did not know their treatment target, which can contribute to 
uncontrolled BP, similar to previous studies conducted in China and SA [21,38].   
 
Encouragingly as well, more than half of the patients were aware of the fact that social habits 
are also associated with BP control (Table 2) and were involved in some form of physical 
activity (Table 3). Most of the patients were also not consuming alcohol and were not smoking 
(Table 3). Half of the patients indicated reducing or stopping salt intake can assist in reducing 
high BP, which is also encouraging (Table 4). However, other factors such as avoiding stress 
and fatty foods were considerably less well known (Table 4). Consequently, knowledge on 
possible social habits and lifestyle modifications needs to be improved to help further control 
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hypertension alongside education generally of the disease [23,25,37,39].   This will help 
address the finding that the majority of patients in our study indicated the need to receive more 
information about hypertension and its management. Nearly three quarters of patients indicated 
a need to receive more information on hypertension in general, followed by the need for 
information on lifestyle changes (Figure 2). The appreciable difference in percentages of 
patients who need different types of information on hypertension (Figure 2) could be linked to 
the possibility that these patients are not receiving the appropriate information about 
hypertension in the first place. Consequently, as mentioned, it is important for all health care 
providers in PHC facilities FRQWLQXRXVO\ DVVHVV K\SHUWHQVLYH SDWLHQWV¶ XQGHUVWDQGLQJ DQG
knowledge of their disease. Whilst few patients indicated the need for information on 
hypertensive medicines (Figure 1), a number of them were not sure what kind of information 
they received. This again is an indication that hypertensive patients should receive educational 
information regularly [39-41].  In view of this, there is a need to improve on the mode of 
delivering hypertension information at PHC clinics in SA especially with issues such as access 
being resolved with the NHI system and CCMDD programmes, which has been a concern in 
some countries and centres [42]. This is especially important in patients with limited or no 
education who cannot read or interpret instructions [23-25,42].  
 
&RQVLGHULQJ SKDUPDFLVWV¶ training and scope of practice [43], they are well-positioned to 
develop and implement strategies along with physicians to improve patients¶ knowledge on 
hypertension and its management to subsequently improve treatment outcomes [16,44-48]. The 
pharmacist¶Vrole could be to help verify that patients can demonstrate sufficient knowledge 
and skills to follow their pharmacotherapeutic regimens and monitoring plans, as well as 
motivate them to learn about their treatment and actively participate in their own care [49]. In 
addition, pharmacists could also participate generally to improve health care literacy [49-51]. 
This is imperative given the high and growing public health burden of NCDs including 
hypertension in SA. The introduction of the NHI system with the re-engineering of PHC 
services, including the CCMDD programme, creates the ideal opportunity for this [13]. 
 
We are aware of the limitations in this study. These include the fact that the study was only 
conducted in one province of SA. For some of the questions, data were missing, which affected 
the sample size for these questions. However, in view of the importance of this province and 
district, as an NHI pilot site and part of the CCMDD programme, we believe that the findings 
are robust and can provide direction to the authorities as they progress with the CCMDD 
programmes to reduce the morbidity and mortality of NCDs in SA.  
 
6. Conclusion  
 
Although the majority of the patients in this study had basic knowledge on hypertension, they 
lacked hypertension specific knowledge such as knowledge about what hypertension is, what 
the normal BP should be, that both systolic and diastolic readings are important, and what 
activities can be undertaken such as exercise to better control BP. This is a concern as the 
Vhembe District is one of the NHI pilot districts in which the CCMDD programme is being 
implemented. Consequently, it is imperative to develop educational intervention strategies 
among PHC facilities, to conduct research on the development and piloting of such activities, 
and to address knowledge gaps. Co-ordinated programmes are important to improve the 
management of patients with chronic diseases already in the CCMDD programme and those 
still to be registered on the programme, given the prevalence of hypertension in South Africa. 
The results showed that there is a need to continuously give hypertension information to 
patients to empower them with specific knowledge on hypertension. Pharmacists can be part 
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of this programme. This is important as more low and middle income countries strive to provide 
universal access of care to patients, especially those with chronic NCDs such as hypertension. 
 
7. Executive Summary  
x Half of patients had uncontrolled hypertension despite an appreciable number on treatment 
for five years or more, which is a concern given the high prevalence rates of hypertension 
in South Africa 
x There is typically a lack of literacy and formal education among patients seeking care at 
PHC facilities in South Africa and wider. As a result, it is important that verbal instructions 
are given alongside any written instructions, and multi-disciplinary teams are involved so 
messages are repeated, to improve medicine taking and adherence as well as lifestyle 
changes   
x The majority of patients knew that hypertension is dangerous to health; however limited 
knowledge of BP numbers, except among the educated, and their rationale 
x Patients were aware that reducing salt intake would help reduce hypertension but not factors 
such as avoiding stress or fatty foods. This needs addressing 
x More needs to be done in South Africa as it rolls out its Central Chronic Medicines 
Dispensing and Distribution (CCMDD) programme to improve the availability and 
accessibility of medicines to patients with chronic diseases to ensure the morbidity and 
mortality from hypertension is reduced from current high levels 
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